Elutia Inc. Class A Common Stock

ELUTNASDAQ • USD
0.78 USD
↘ 0.02 (2.66%)AT CLOSE (03:59 PM EDT)
0.73
↘ 0.05 (6.25%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.73
↘ 0.05 (6.25%)
🔴Market: CLOSED

Elutia Inc. Class A Common Stock (ELUT) trades at $0.78 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (329.0%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 2, 2026.

Open?$0.78
High?$0.82
Low?$0.67
Prev. Close?$0.80
Volume?1.3M
Avg. Volume?285.1K
VWAP?$0.74
Rel. Volume?4.57x
Bid / Ask
Bid?$0.66 × 100
Ask?$0.88 × 100
Spread?$0.22
Midpoint?$0.77
Valuation & Ratios
Market Cap?34.5M
Shares Out?44.3M
Float?32.5M
Float %?73.3%
P/E Ratio?0.67
P/B Ratio?2.19
EPS?$1.17
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Employees
26
Market Cap
34.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-10-08
Address
12510 PROSPERITY DRIVE
SILVER SPRING, MD 20904
Phone: 240-247-1143
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
0
Momentum?
21
Short Sent.?
80
Piotroski F-Score?6/9Mixed
Altman Z-Score?-6.64Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.03%Low
Short Interest?8.2K
Days to Cover?1.0
Free Float32.5M
Avg Daily Volume27.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.77Adequate
Quick Ratio?1.64Adequate
Cash Ratio?0.95Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
0.7CHEAP▾
P/B?
Peers
100
S&P
70
2.19CHEAP▾
P/S?
Peers
100
S&P
53
2.85CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.7CHEAP▾
EV/Sales?
Peers
100
S&P
88
1.21CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
329.0%STRONG▾
ROA?
Peers
50
S&P
97
118.7%STRONG▾
Cash Flow & Enterprise
FCF?$-46027000
Enterprise Value?$14.6M
Fundamentals ratios updated end of day